A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 38/19 (2006.01) C07K 16/24 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2182723
The invention pertains to the use of TNF antagonists in producing drugs to treat diseases that are characterized by elevated interleukin- 6 serum levels.
L'invention concerne l'utilisation d'antagonistes du facteur de nécrose des tumeurs (TNF) pour préparer des médicaments utilisés dans le traitement de maladies caractérisées par une élévation du taux sérique d'interleukine 6.
Daum Lothar
Kaul Martin
Kempeni Joachim
Raab Christa
Schaefer Sibylle
Abbott Gmbh & Co. Kg
Robic
LandOfFree
The use of anti-tnf antibodies as drugs for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with The use of anti-tnf antibodies as drugs for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of anti-tnf antibodies as drugs for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1750700